Pharmaceutical Services urge patients not to stop treatment after Remedica recall
The Pharmaceutical Services said patients affected by Remedica’s recall should follow medical advice and not discontinue medication independently.
Nicosia, Cyprus. The Pharmaceutical Services have urged patients not to stop taking medication following Remedica’s recall of several batches of nine pharmaceutical products, warning that discontinuing treatment without medical advice could have serious consequences.
The service said alternative medicines containing the same active substance, or suitable replacement treatments, had been identified for the vast majority of recalled products.
Medical advice
“Patients should under no circumstances discontinue their treatment on their own,” the Pharmaceutical Services said. “They are urged to follow the instructions of their treating physician and, where necessary, proceed with a replacement treatment in accordance with the relevant medical instructions.”
The service said all necessary measures were being taken to ensure continuity of treatment.
Reason for recall
The issue concerns product stability parameters and does not involve findings of toxicity or evidence that the products are harmful to patients, the Pharmaceutical Services said.
It described the recall as a precautionary measure under safety regulations governing the production and distribution of pharmaceutical products.
According to the service, Remedica voluntarily recalled specific products after stability studies identified results outside specified limits.
“By its nature, such a recall cannot be predicted or scheduled in advance,” the service said, adding that the company and competent authorities activated the required procedures immediately after the matter was identified.
Affected products
Remedica announced the recall on Monday, covering several batches of nine pharmaceutical products, while stating that there were no safety concerns for patients using the affected medicines.
The recalled medicines include Carvidex, a prescription beta-blocker used to treat high blood pressure, angina and heart failure, and Clonotril, which is primarily used to treat seizure disorders and panic or anxiety.
The recall required doctors to amend prescriptions. Patients also reported difficulties contacting their doctors or local pharmacies, which remained closed ahead of the upcoming holiday.
This news item was generated automatically by Cyprus Inform from publicly available materials. Report an error →
